Customer Transformations in Pharma

Christophe Jauquet
2 days ago
6 min read

Your Strategic Plan Is Missing What Matters Most...

Welcome to "It's a Healthusiasm World ".

Every now and then, this newsletter explores and explains business strategies that shape the future of health.

More than 5.500 people subscribed to Healthusiasm already.

You can also join for free: www.christophejauquet.com/blog

There’s a ritual in pharma that repeats itself every spring. Between April and June, commercial teams across the globe retreat into strategic planning season. Budgets are reviewed. Brand plans are updated. KPIs are set for the year ahead. And almost everywhere, the same question lingers beneath the surface: Are we still relevant to the people we serve?

The honest answer, for most companies, is: less than you think.

Not because the science is wrong. Not because the products don’t work. But because the way pharma engages with physicians and patients is built on a logic that the rest of the world has already moved beyond.

HCPs don’t want your product information anymore. They want partners who help them deliver better outcomes for patients who are more demanding than ever.

This is not a soft, aspirational statement. It is the hard commercial reality facing every pharmaceutical business unit preparing for 2027 right now. Physicians have access to all the clinical data they need. What they lack — and what they look for in a partner — is help navigating a world where patients arrive informed, opinionated, and with expectations shaped by every other industry they interact with.

The pharma companies that understand this shift will not just differentiate from competitors. They will own HCP access for the next decade.

From Products to Experiences Was Not Enough

Over the past ten years, most pharmaceutical companies have invested in upgrading their commercial model. Digital tools for HCPs. Patient support programmes. Beyond-the-pill services. Omnichannel engagement strategies. All of this moved pharma from a purely product-driven approach towards a more service- and experience-oriented one.

That was necessary. But it was not sufficient.

Here is why. When every company starts offering similar services and digital experiences, none of them stand out anymore. This is exactly what happened in consumer industries before pharma: when experiences become commoditised, customers opt for the cheapest or most convenient option. Differentiation disappears.

The next step — the one that most pharma companies have not yet taken — is what I call the Transformation Economy.

A great customer experience is no longer enough.

People seek Customer Transformations that make them feel better, healthier and happier.

The Transformation Economy is not a trend. It is a structural shift in how value is created. Products and services meet needs. Experiences meet expectations. But Customer Transformations meet something deeper: the life aspirations of the people you serve.

In every other industry — from fitness to food, from automotive to finance — the companies that create the most value are no longer those with the best product or even the best experience. They are the ones that help their customers pursue what matters most in their lives. That is the transformation. And that is what pharma’s strategic plan should be built around.

What Customer Transformations Look Like in Pharma

Let me make this concrete. A pharmaceutical company has a product for patients with Crohn’s disease. The product works. The clinical data is solid. The HCP detail aid presents the efficacy, safety and tolerability profile clearly.

But none of that speaks to what the patient actually wants.

A Crohn’s patient does not just want symptom relief. That patient wants to go out with friends without anxiety. Wants to travel. Wants to feel normal. Wants meaningful connections without the constant fear of a flare-up. These are Life Aspirations — universal human desires like Calmness, Relationships, Autonomy, and Joy.

Customer Needs × Customer Expectations × Life Aspirations

= Customer Transformations

The formula for creating value in the Transformation Economy

When your commercial team learns to communicate how your solution helps patients pursue these aspirations — not just manage a condition — you change the conversation entirely. The HCP stops seeing you as another product supplier. The patient stops seeing the treatment as a burden. Both start seeing your company as a partner in something that matters to them.

Pharmaceutical companies believe they are more patient-centric than they actually are. Only 38% of patients agree that pharma listens to them.

That gap between what pharma believes and what patients experience is the commercial opportunity of this decade. The companies that close it during this strategic planning season will build a competitive advantage that cannot easily be copied — because it is rooted in genuine relevance, not in features.

Why Strategic Planning Season Is the Moment

This is not something you can bolt onto a running brand plan. Customer Transformations require a fundamentally different starting point — one that begins with the life aspirations of your stakeholders rather than the clinical profile of your product.

That is precisely why strategic planning season is the right moment. It is the one window in the year where teams step back from execution and ask: What are we actually trying to achieve? And for whom?

Here is what this means in practice:

1. Redefine what value means

Move from product-centric value (efficacy, safety) to transformation-centric value (helping patients pursue their Life Aspirations through your solution).

2. Redesign HCP engagement

Stop leading with product. Start designing engagement around what physicians and patients actually expect — not just what they clinically need.

3. Align your team’s capabilities

Commercial teams need to understand the Transformation Economy and be equipped with frameworks — like the Life Aspirations Model and the Customer Transformation Model — to apply it in their therapeutic area.

4. Build it into the brand plan

Customer Transformations should not be a separate initiative. They should be the lens through which every commercial decision is made — from positioning to field force messaging to patient support design.

The commercial model that wins in 2030 is being designed right now.

The structural decisions in the next 12–24 months will define your competitive position for the next decade.

Book a 15-min Call

What This Has Done for Others

This is not theory. I have worked with commercial teams across the world’s largest pharmaceutical companies to make this shift concrete and actionable.

RECENT ENGAGEMENTS

After working with Roche across 12 countries in the Middle East and APAC, commercial teams stopped leading with product and started designing engagement around what physicians and patients actually expect. Similar transformations have been delivered with Novo Nordisk across 9 European countries, AbbVie Global, and Pfizer Global. I’ve worked for every pharmaceutical company in the global top 20.

What changes after these engagements is not just the messaging. It is the way teams think about their role. They stop being product promoters. They start being transformation partners. And that shift is what makes HCPs want to give them time.

It Starts Closer to Home Than You Think

There is a productive paradox at the heart of this shift: the healthcare industry should be best positioned for Customer Transformations, yet it is often the least prepared.

Every pharmaceutical company has a mission statement about improving lives. Every brand plan mentions patient-centricity. But between the mission on the wall and the reality in the field, there is a gap. Filling that gap — making your company’s purpose tangible in every HCP conversation and every patient touchpoint — is what the Transformation Economy demands.

The good news: it is not that difficult. It requires a different starting point, not a different organisation. The Life Aspirations Model provides the language. The Customer Transformation framework provides the structure. And your team already has the knowledge of their therapeutic area to make it specific and relevant.

Aspirations are the new needs. If you know what Life Aspirations your patients pursue, you help them become healthy and happy. That is what they value most.

This is your company’s chance to do something your competitors are not yet doing. Not because they can’t, but because they haven’t been shown how. Strategic planning season is the window. The question is whether you use it.

---

Christophe Jauquet is the author of Healthusiasm (2018) and Trends in the Transformation Economy (2024), and has spent 25+ years in healthcare and pharmaceutical strategy. He works with global pharma teams to translate the Transformation Economy into actionable commercial strategy.